Latest ROE for Seer: -29.19% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-29.19%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Seer (SEER) currently reports a ROE of -29.19%. That is below the Healthcare sector average of 29.33%. Use the charts on this page to explore Seer's ROE history and peer comparisons.
Seer's ROE of -29.19% is lower than the Healthcare sector average of 29.33%. That is roughly 199.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Seer's current -29.19% should be judged against Healthcare norms (sector average: 29.33%) and against SEER's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -29.19%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for Seer, and consider following SEER for alerts when major investors trade the stock.
Seer is classified in the Healthcare sector. On ROE, it currently shows -29.19% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SEER with unrelated industries.